Translate page

  • Presentations from the EHA2022 Congress

  • EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)

  • EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)

  • COLT Meeting 2019: CML related topics

  • COLT Meeting 2019: The CML frontier

    Millot EHA 2019

    Mechanisms for Resistance and TFR in CML: Special Aspects in Children
    Professor Fréderic Millot, University of Poitiers, France 

    • Clinical and biological characteristics of childhood CML
    • Mechanisms of failure of tyrosine kinase inhibitors in children with CML
    • Criteria for discontinuation of tyrosine kinase inhibitors in children with CML
    • Childhood CML: Conclusion



    This talk was first presented during the Hematology-in-Focus Session on 'Mechanisms for resistance and treatment-free remission (TFR) in CML' at EHA. You will find more education materials from EHA at the EHA Learning Centre